RegenXBio share price logo

RegenXBio

NASDAQ: RGNX

Small Cap

$11.33

+0.56

(+5.25%)

as on

RegenXBio Stock Performance

as on August 18, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $10.53
    $11.36
    downward going graph

    7.06%

    Downside

    0.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.46
    $16.19
    downward going graph

    51.85%

    Downside

    42.89%

    Upside

    downward going graph

RegenXBio share price movements today

Previous Close
$10.77
Open
$10.72
Volume
970.3K
Market Cap
$710.6M
Day's Low - High
$10.53 - $11.36
52 Week Low - High
$5.46 - $16.19

RegenXBio Historical Returns

1 Month Return
+ 8.85 %
3 Month Return
+ 88.2 %
1 Year Return
+ 22.05 %
3 Year Return
-39.15 %
5 Year Return
-65.78 %

RegenXBio Stock Fundamentals & Key Indicators

Check RegenXBio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$710.6M

EPS (TTM)

-3.4298

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.26

EBITDA

-148.8M

Revenue (TTM)

174.5M

Profit Margin

-112.58%

Return On Equity TTM

-137.63%

RegenXBio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of RegenXBio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
RegenXBio image
RegenXBio
BUY$710.6M-65.78%NA-112.58%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for RegenXBio Stock including INR - Dollar returns

The RegenXBio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

RegenXBio investment value today

Current value as on today

₹1,40,642

Returns

₹40,642

(+40.64%)

Returns from RegenXBio Stock

₹28,458 (+28.46%)

Dollar Impact

₹12,184 (+12.18%)

Analyst Recommendation on RegenXBio Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for RegenXBio. Average target price of $24.55

RegenXBio Share Price Target

Get share price movements and forecasts by analysts on RegenXBio.

What analysts predicted

53.85%UPSIDE

Target Price

$24.55

Current Price

$11.33

Analyzed by

10 Analysts

Target

$24.55

RegenXBio target price $24.55, a slight upside of 53.85% compared to current price of $11.33. According to 10 analysts rating.

Indian Investors' Interest in RegenXBio Stock

Search interest for RegenXBio Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

RegenXBio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
15
22
24
21
89
21
29
30
6
108
Gross Profit
7
7
11
14
85
12
-32
24
-4
106
Operating Income
-61
-56
-62
-51
12
-63
-52
-57
-83
29
EBITDA
-57
-48
-54
-37
18
-55
-44
-51
-77
34
Interest Expense
1
0
0
9
8
10
13
12
8
7
Depreciation
4
4
3
4
3
3
3
3
3
3
Income Before Tax
-63
-52
-59
-51
6
-70
-61
-67
-90
22
Income Tax Expense
0
-
-
-
-
-
-
-
-
-
Net Income
-63
-52
-59
-51
6
-70
-61
-67
-90
22
Net Profit Margin
-405.39%
-237.67%
-246.30%
-241.28%
6.83%
-331.81%
-208.32%
-221.34%
-1408.59%
21.02%

RegenXBio Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4
10
218
35
154
470
112
90
83
170
Gross Profit
3
8
208
26
118
418
58
53
49
150
Operating Income
-65
-75
88
-148
-119
159
-262
-268
-233
-161
EBITDA
-64
-73
92
-90
-96
177
-244
-239
-198
-133
Interest Expense
-
-
-
107
0
26
23
6
12
45
Depreciation
-
2
3
7
8
9
12
17
16
15
Income Before Tax
-63
-73
104
-97
-106
141
-280
-263
-227
-193
Income Tax Expense
0
0
4
-2
5
13
0
0
-
-
Net Income
-62
-73
99
-94
-111
127
-280
-263
-227
-193
Net Profit Margin
-1372.13%
-704.02%
45.74%
-268.88%
-71.98%
27.18%
-248.68%
-291.99%
-272.54%
-113.75%

RegenXBio Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-52
-59
-51
6
-70
-61
-67
-90
22
Operating Cash Flow
-45
-40
-31
33
-49
-55
-52
-76
-62
Investing Cash Flow
0
50
40
44
-140
42
37
70
65
Financing Cash Flow
-9
-10
-7
-5
139
-7
-9
-13
17
Change in Cash
-55
-1
0
72
-50
-20
-24
-19
21

RegenXBio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-73
99
-94
-111
127
-280
-263
-227
-193
Operating Cash Flow
-57
104
-107
-54
218
-207
-218
-173
-123
Investing Cash Flow
-4
-279
93
122
-406
-11
190
103
-15
Financing Cash Flow
84
204
8
200
195
-28
-34
92
116
Change in Cash
21
29
-5
268
7
-248
-62
23
-23

Mutual Funds that own RegenXBio Stock

Check out the Mutual Funds with significant holdings in RegenXBio.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.968546%
1959632
JPMorgan Trust II
2.276867%
1503033
TIAA-CREF Funds
1.210956%
799391
BlackRock Funds
0.935119%
617302
JPMorgan Trust I
0.829188%
547374
See all

Global Institutional Holdings in RegenXBio

Funds
Holdings
Vanguard
3.83%
iShares
3.66%
SPDR
3.24%
Fidelity
0.54%
Schwab
0.42%
See all

RegenXBio News & Key Events

  • img

    Today's Timeline - 06 August

    Thu, 04:35 PM

    -

    REGENXBIO reports Q2 2026 results: $108M revenue, $22.7M net income, and plans for RGX-202 BLA submission in Q3 2026.

Insights on RegenXBio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RGNX stock has moved up by 100.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 6.39M → 108.01M (in $), with an average increase of 94.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -90.05M → 22.70M (in $), with an average increase of 496.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 451.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 651.5%

About RegenXBio

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
OrganisationRegenXBio
Headquarters9804 Medical Center Drive, Rockville, MD, United States, 20850
IndustryBiotechnology
CEOMr. Curran M. Simpson M.S.
E-voting on sharesClick here to vote

Key Management of RegenXBio

Name

Title

Mr. Patrick J. Christmas II, J.D.

Executive VP & Chief Strategy and Legal Officer

Ms. Nina Hunter

SVP of Global Regulatory Strategy and Quality

Dr. Jahannaz Dastgir D.O.

Clinical Development Lead

Mr. Curran M. Simpson M.S.

President, CEO & Director

Mr. Mitchell Chan M.B.A.

Executive VP & CFO

Mr. Craig Malzahn

Executive VP of Product Development & CTO

Dr. Olivier Danos Ph.D.

Executive VP & Chief Scientific Officer

Ms. Shiva G. Fritsch

Chief Communications & People Officer

Dr. Ram Palanki Pharm.D.

Executive VP & Chief Commercial Officer

Dr. Stephen Pakola M.D.

Executive VP & Chief Medical Officer

FAQs

What is RegenXBio share price today?

RegenXBio share price today is $11.33 as on at the close of the market. RegenXBio share today touched a day high of $11.36 and a low of $10.53.

What is the 52 week high and 52 week low for RegenXBio share?

RegenXBio share touched a 52 week high of $16.19 on and a 52 week low of $5.46 on . RegenXBio stock price today i.e. is closed at $11.33,which is 30.02% down from its 52 week high and 107.70% up from its 52 week low.

What is RegenXBio's market capitalisation today?

RegenXBio market capitalisation is $0.00T as on .

How to invest in RegenXBio Stock (RGNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for RegenXBio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in RegenXBio Shares that will get you 0.1324 shares as per RegenXBio share price of $11.33 per share as on August 18, 2026 at 8:46 am IST.

What is the minimum amount required to buy RegenXBio Stock (RGNX) from India?

Indian investors can start investing in RegenXBio (RGNX) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in RegenXBio stock (as per the Rupee-Dollar exchange rate as on ). Based on RegenXBio share’s latest price of $11.33 as on August 18, 2026 at 8:46 am IST, you will get 0.8826 shares of RegenXBio. Learn more about fractional shares .

What are the returns that RegenXBio has given to Indian investors in the last 5 years?

RegenXBio stock has given -65.78% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?